Document:

Exhibit 10.2

 

DEBT CONVERSION AGREEMENT

 

This Debt Conversion
Agreement (the “Agreement”) is made and entered into this 20 day of April 2018 (the “Effective Date”) between
US-China Biomedical Technology, Inc. fka Cloud Security Corporation, a Nevada corporation ("Company") and China Israel
Biological Technology Co. Ltd. (the “Creditor”). The Company and Creditor are sometimes referred to herein individually
as the “Party” or collectively as the “Parties”.

 

RECITALS

 

A.       WHEREAS,
the Company owes to Creditor an aggregate amount of $223,694 US Dollars in principal and $6,500.77 in accrued interest owed through
May 1, 2018 (collectively the “Debt”) pursuant to a series of four short term certain promissory notes attached hereto
as Exhibit A. By and through this Agreement the Parties have agreed to convert 100% of the Debt owed by Company to Creditor into
a portion of the purchase price for the subscription of shares of common stock in the company, in lieu of cash repayment;

 

B.               WHEREAS,
the Company and Creditor mutually agree to settle the Debt by and through the application of the Debt as a portion of the purchase
price for restricted shares of the Company’s common stock at a price per share valued at $0.40 per share as set forth on
the Subscription Agreement attached hereto as Exhibit B (the “Subscription Agreement”);

 

C.               WHEREAS,
as a result of negotiations between the Company and Creditor, the Parties have proposed a resolution that they deem to be fair
and equitable, and by this Agreement, Creditor and the Company wish to compromise, resolve, waive and release any and all claims,
known or unknown, by and between them as fully set forth herein which exist or may exist today as it pertains to the Debt; and

 

D.              WHEREAS,
each Party, without admitting any liability whatsoever, enters into this Agreement to settle all disputes, claims and actions between
the Parties, as well as to settle any and all events or relationships between the Parties.

 

AGREEMENT

 

NOW, THEREFORE,
in consideration of the mutual covenants set forth in this Agreement, and for other good and valuable consideration, the receipt
and adequacy of which is acknowledged, the Parties covenant and agree as follows:

 

A.               Recitals. The foregoing recitals are true and correct and incorporated by reference herein.

 

B.               Consideration. As full consideration for this Agreement hereunder, (i) the Company shall apply the Debt towards
the purchase under the Subscription Agreement, (ii) the Creditor shall be issued restricted shares of the Company’s common
stock, at a price per share valued at $0.40 per as set forth in Subscription Agreement (the “Settlement Shares”) and,
in exchange, (iii) Creditor shall grant to Company a full settlement and release in connection with the Debt.

 

C.               Mutual Release. Each Party, on behalf of himself or itself and his or its successors, officers, directors, administrators,
representatives, insurers, agents and assigns hereby releases and forever discharges the other Party, its predecessors, successors,
parents, subsidiaries, nominees and affiliates and all present and former officers, directors, partners, principals, employees,
attorneys, insurers, agents and their respective administrators, representatives, spouses, heirs, agents and assigns from any and
all claims, and causes of action and any other claim they have, whether currently known or unknown, foreseen or unseen, suspected
or unsuspected. It is understood and agreed that, except as provided herein and by the attached documents incorporated herein by
reference, this Agreement shall constitute a broad general release by each Party for the benefit of the other Party and shall be
effective as a full and final accord and satisfaction, and as a bar to all actions, causes of action, costs, expenses, claims for
sanctions, attorneys' fees, and damages, including claims now pending in any action, indemnity or contribution by any party or
third party, or their counsel, or any other claims or liabilities whatsoever, whether or not now known, suspected, claimed or concealed
that are related to any action or claim. This general release includes but is not limited to any and all claims, causes of action,
damages or accounts that now exist or may exist in the future arising out of any matters, agreements, omissions, representations
made, money due, money paid, or any other relationship between the Parties at any time prior to the date hereof. It is the intention
of all Parties to fully discharge and release the remaining Parties with respect to any and all matters, claims, causes of action,
contracts or expenses arising from any matter. Each Party acknowledges that it is familiar with Section 1542 of the California
Civil Code which provides as follows:

 

 

 

    	 	1	 

     

    

 

A GENERAL RELEASE
DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS FAVOR AT THE TIME OF EXECUTING THE RELEASE,
WHICH IF KNOWN BY HIM MUST HAVE MATERIALLY AFFECTED HIS SETTLEMENT WITH THE DEBTOR.

 

Except as provided for
herein, the Parties expressly waive and relinquish any and all rights and benefits which it may have under, or which may be conferred
upon him by the provisions of Section 1542 of the California Civil Code, as well as under any other similar state or federal statute
or common law principle, to the fullest extent that they may lawfully waive such rights or benefits. In connection with their waiver
and relinquishment set forth in the previous paragraphs, each Party acknowledges that he or it is aware that he or it may hereafter
discover claims or facts in addition to or different from those which he, she or it now knows or believes to exist with respect
to the subject matter of this Agreement, but it is his or its intention to fully, finally and forever settle and release all of
the disputes and differences known or unknown, suspected or unsuspected which do now exist, may exist in the future or have ever
existed between the Parties. In furtherance of such intention, the Parties agree that this Agreement shall remain in effect as
a full and complete settlement in perpetuity.

 

D.              
Representations and Warranties of the Company. The Company hereby represents and warrants to Creditor as follows:

 

a.               
All of the issued and outstanding shares of the Company's common stock are, and all shares reserved for issuance will
be, upon issuance in accordance with the terms specified in the instruments or agreements pursuant to which they are issuable,
duly authorized, validly issued, fully paid and non-assessable. The Settlement Shares to be issued and delivered to Creditor have
been duly authorized and when issued upon such conversion, will be validly issued, fully-paid and non-assessable.

 

b.               
The Company has full legal power to execute and deliver this Agreement and to perform its obligations hereunder. All
acts required to be taken by the Company to enter into this Agreement and to carry out the transactions contemplated hereby have
been properly taken, and this Agreement constitutes a legal, valid and binding obligation of the Company, enforceable in accordance
with its terms and does not conflict with, result in a breach or violation of or constitute (or with notice of lapse of time or
both constitute) a default under any instrument, contract or other agreement to which the Company or its subsidiaries is a party.

 

c.               
None of the Company's Articles of Incorporation, as amended, or Bylaws, or the laws of the State of Nevada contains
any applicable provisions or statute which would restrict the Company's ability to enter into this Agreement or consummate the
transactions contemplated by this Agreement or which would limit any of Creditor’s rights following consummation of the transactions
contemplated by this Agreement.

 

d.               
No broker, finder or investment banker is entitled to any brokerage, finder's or other fee or commission in connection
with the transactions contemplated by this Agreement based upon arrangements made by or on behalf of the Company.

 

e.               
The Company has delivered or made available to Creditor prior to the execution of this Agreement true and complete copies
of all financial statements of the Company.

 

E.              
Representations and Warranties of Creditor. Creditor represents and warrants to the Company as follows:

 

a.               
Creditor has full legal power to execute and deliver this Agreement and to perform its obligations hereunder. All acts
required to be taken by Creditor to enter into this Agreement and to carry out the transactions contemplated hereby have been properly
taken; and this Agreement constitutes a legal, valid and binding obligation of such Creditor enforceable in accordance with its
terms.

 

b.               
Creditor has reviewed the financial statements of the Company.

.

c.               
Creditor has been given an opportunity to ask questions and receive answers from the officers and directors of the Company
and to obtain additional information from the Company.

 

 

 

    	 	2	 

     

    

 

d.               
Creditor has such knowledge and experience in financial and business matters as to be capable of evaluating the merits
and risks of an investment in the Company's securities and has obtained, in its judgment, sufficient information about the Company
to evaluate the merits and risks of an investment in the Company.

 

e.               
Creditor is relying solely on the representations and warranties contained herein and in financial statements made available
in making its decision to enter into this Agreement and consummate the transactions contemplated hereby and no oral representations
or warranties of any kind have been made by the Company or its officers, directors, employees or agents to such Creditor.

 

F.               
Conditions.

 

a.               
The obligations of the Company to consummate the transactions contemplated by this Agreement shall be subject to the
fulfillment of the following conditions:

 

i.               The representations and warranties of Creditor set forth herein shall be true and correct on and as of the Effective
Date.

 

ii.              All proceedings, corporate or otherwise, to be taken by the Creditor in connection with the consummation of the transactions
contemplated by this Agreement shall have been duly and validly taken and all necessary consents, approvals or authorizations of
any governmental or regulatory authority or other third party required to be obtained by the Company or Creditor shall have been
obtained in form and substance reasonably satisfactory to the Company.

 

b.               
The obligations of Creditor to consummate the transactions contemplated by this Agreement shall be subject to the fulfillment
of the following conditions:

 

i.                The representations and warranties of the Company set forth herein shall be true and correct on and as of the Effective
Date.

 

ii.              All proceedings, corporate or otherwise, to be taken by the Company in connection with the consummation of the transactions
contemplated by this Agreement shall have been duly and validly taken and all necessary consents, approvals or authorizations of
any governmental or regulatory authority or other third party required to be obtained by the Company or Creditor shall have been
obtained in form and substance reasonably satisfactory to Creditor.

 

iii.             The Company shall have caused the Settlement Shares to be approved for issuance.

 

G.              
Restrictive Legend. The Settlement Shares that shall be issued by the Company pursuant to this Agreement will
not have been registered and are being issued pursuant to a specific exemption under the Securities Act, as well as under certain
state securities laws for transactions by an issuer not involving any public offering or in reliance on limited federal preemption
from such state securities registration laws. The Settlement Shares to be issued by the Company pursuant to this Agreement must
be held and may not be sold, transferred, or otherwise disposed of for value unless such securities are subsequently registered
under the Securities Act or an exemption from such registration is available, and that the certificates representing the shares
of the Company issued pursuant to this Agreement will bear a legend in substantially the following form so restricting the sale
of such securities:

 

The securities
represented by this certificate have not been registered under the Securities Act of 1933, as amended (the “Securities Act”),
and are “restricted securities” within the meaning of Rule 144 promulgated under the Securities Act. The securities
have been acquired for investment and may not be sold or transferred without complying with Rule 144 in the absence of an effective
registration or other compliance under the Securities Act.

 

H.              
Entire Agreement; No Oral Modification. This Agreement constitutes the complete and entire written agreement
of compromise, settlement and release between the Parties and constitutes the complete expression of the terms of the settlement.
All prior and contemporaneous agreements, representations, and negotiations are superseded and merged herein. The terms of this
Agreement can only be amended or modified by a writing, signed by duly authorized representatives of all Parties hereto, expressly
stating that such modification or amendment is intended.

 

 

 

    	 	3	 

     

    

 

I.                
Authority to Execute. Each Party executing this Agreement represents that it is authorized to execute this Agreement.
Each person executing this Agreement on behalf of an entity, other than an individual executing this Agreement on his or her own
behalf, represents that he or she is authorized to execute this Agreement on behalf of said entity.

 

J.               
Voluntary Agreement. The Parties have read this Agreement, have had the benefit of counsel and freely and voluntarily
enter into this Agreement.

 

K.              
Counterparts. This Agreement may be executed in counterparts and, if so executed, each counterpart shall have
the full force and effect of an original. Further, a telecopied signature page by any signatory shall constitute an original for
all purposes.

 

L.              
Severability. In the event that any provision contained in this Agreement shall be (i) held by any court or arbitration
tribunal to be unenforceable, illegal, void or contrary to public policy, or (ii) in conflict with any applicable statute, law,
regulation or applicable collective bargaining agreement, then such provision shall be of no force or effect; provided, however,
that in such event the provision of this Agreement so affected shall be curtailed and limited only to the minimum extent necessary
to permit compliance with the minimum required, and no other provisions of this Agreement shall be affected thereby and all such
other provisions shall continue in full force and effect.

 

M.             
Ambiguity. Any rules of interpretation that ambiguities are to be construed against the drafting party shall
not apply.

 

N.              
Governing Law. This Agreement is being executed and delivered, and is intended to be performed, in the State
of Nevada, and to the extent permitted by law, the execution, validity, construction, and performance of this Agreement shall be
construed and enforced in accordance with the laws of the State of Nevada without giving effect to conflict of law principles.
This Agreement is intended to resolve all claims, known or unknown, between the Company and Creditor in any jurisdiction.

 

 

 

 

 

<REST OF THIS PAGE INTENTIONALLY LEFT
BLANK;

PLEASE SEE FOLLOWING PAGE FOR SIGNATURE>

 

 

 

    	 	4	 

     

    

 

IN WITNESS WHEREOF,
the Parties have entered into this Agreement made and effective as of the date first hereinabove written.

 

	 	US-CHINA BIOMEDICAL TECHNOLOGY, INC.
	 	 
	 	 
	Dated:  April 20, 2018	By:  /s/ Qingxi Huang          
	 	Name:  Qingxi Huang
	 	Title:    Chief Executive Officer and Director
	 	 
	 	 
	 	 
	 	 
	 	CREDITOR - China Israel Biological Technology Co. Ltd.
	 	 
	Dated:  April 20, 2018	By:  /s/ Qingxi Huang      
	 	Name:  Qingxi Huang
	 	Title:    President

 

 

 

 

 

 

    	 	5EX-10.1

 Exhibit 10.1 

SYNEOS HEALTH, INC. 

2018 EQUITY INCENTIVE PLAN 

(adopted by the Board of Directors on March 15, 2018 and 

approved by the Shareholders of the Company on May 24, 2018) 

1.    Purpose. The purpose of the Syneos Health, Inc. 2018 Equity Incentive Plan is to further align the
interests of eligible participants with those of the Company’s stockholders by providing long-term incentive compensation opportunities tied to the performance of the Company and its Common Stock. The Plan is intended to advance the interests
of the Company and increase stockholder value by attracting, retaining and motivating key personnel upon whose judgment, initiative and effort the successful conduct of the Company’s business is largely dependent. 

2.    Definitions. Wherever the following capitalized terms are used in the Plan, they shall have the meanings
specified below: 
 “Accounting Firm” shall have the meaning set forth in Section 15.8(b)(i) hereof. 

“Affiliate” means, with respect to any Person, any other Person that the subject Person, either directly or indirectly, is
under common control with, is controlled by or controls. 
 “Award” means an award of a Stock Option, Stock Appreciation
Right, Restricted Stock Award, Restricted Stock Unit or Stock Award granted under the Plan. 
 “Award Agreement” means a
notice or an agreement (electronic or written), including any exhibit or appendices thereto) entered into between the Company and a Participant setting forth the terms and conditions of an Award granted to a Participant as provided in
Section 15.2 hereof. 
 “Beneficial Owner” shall have the meaning ascribed to such term in Rule 13d-3 under the
Exchange Act. 
 “Board” means the Board of Directors of the Company. 

“Business Combination” shall have the meaning set forth in Section 12.4(b) hereof. 

“Cause” shall have the meaning set forth in Section 13.2(b) hereof. 

“Change in Control” shall have the meaning set forth in Section 12.4 hereof. 

“Chosen Court” shall have the meaning set forth in Section 15.17 hereof. 

“Code” means the Internal Revenue Code of 1986, as amended, including rules and regulations promulgated thereunder, and any
successor thereto (except as otherwise specified herein). 
 “Committee” means (i) the Compensation Committee of the
Board, (ii) such other committee of the Board appointed by the Board to administer the Plan, or (iii) subject to the terms of the Plan, the Board. 

“Common Stock” means the Company’s Class A common stock, par value $0.01 per share, as the same may be converted,
changed, reclassified or exchanged. 
 “Company” means Syneos Health, Inc., a Delaware corporation, and any successor
thereto. 
 “Date of Grant” means, with respect to any Award under the Plan, the date on which such Award is granted by the
Committee or such later date as the Committee may specify in the resolutions comprising the corporate action constituting such grant by the Company of such Award to be the effective date of an Award, in each case in accordance with Section 5.4
hereof. 

 “Disability” means, unless otherwise set forth in an Award Agreement, 

(i)    if a Participant has an effective employment agreement or service agreement with the Company or a Subsidiary that
defines “Disability” or a like term, the meaning set forth in such agreement at the time of the Participant’s termination of Service, or 

(ii)    in the absence of such an effective employment or service agreement or definition, a Participant’s physical
or mental illness, injury or infirmity which is reasonably likely to prevent and/or prevents such Participant from performing his or her essential job functions for a period of (A) ninety (90) consecutive calendar days or (B) an aggregate
of one hundred twenty (120) calendar days out of any consecutive twelve (12) month period. 
 Notwithstanding anything to the contrary contained
herein, and solely for purposes of any Incentive Stock Option, “Disability” shall mean a permanent and total disability (within the meaning of Section 22(e)(3) of the Code), and solely for purposes of any Award that constitutes non-qualified deferred compensation that is subject to Section 409A of the Code and with respect to which disability is a distribution event, “Disability” shall meet the requirements of
Section 409A of the Code. 
 “EBITDA” shall have the meaning set forth in Section 10.2 hereof. 

“Effective Date” shall have the meaning set forth in Section 16.1 hereof. 

“Eligible Person” means any person who is an employee, Non-Employee Director, consultant or other personal service provider
of the Company or any of its Subsidiaries. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the
rules and regulations promulgated thereunder from time to time. 
 “Fair Market Value” means, with respect to a share of
Common Stock as of a given date of determination hereunder, unless otherwise determined or provided by the Committee in the circumstances, the closing price as reported on the Principal Market on such date or if the Common Stock was not traded on
such date, then on the next preceding trading day that the Common Stock was traded on such exchange, as reported by such responsible reporting service as the Committee may select. The Committee may, however, provide with respect to one or more
Awards that the Fair Market Value shall equal the average of the high and low trading price as reported on the Principal Market on the applicable date of determination, or if the Common Stock was not traded on such date, then on the next preceding
trading day that the Common Stock was traded on such Principal Market, as reported by such responsible reporting service as the Committee may select. If the Common Stock is not listed on any such exchange, “Fair Market Value” shall be such
value as determined by the Board or the Committee in its discretion and, to the extent necessary, shall be determined in a manner consistent with Section 409A of the Code and the regulations thereunder. 

“Forfeiture Event” shall have the meaning set forth in Section 13.2(a) hereof. 

“Incentive Stock Option” means a Stock Option granted under Section 6 hereof that is intended to meet the requirements
of Section 422 of the Code and the regulations thereunder. 
 “Net After-Tax Receipt” shall have the meaning set forth
in Section 15.8(b)(iv)(B) hereof. 
 “Non-Employee Director” means a member of the Board who is not an employee of the
Company or any of its Subsidiaries. 
 “Nonqualified Stock Option” means a Stock Option granted under Section 6 hereof
that is not an Incentive Stock Option. 

  
 2 

 “Outstanding Company Voting Securities” shall have the meaning set forth in
Section 12.4(a) hereof. 
 “Overpayment” shall have the meaning set forth in Section 15.8(b)(iii) hereof. 

“Parachute Payment Ratio” shall have the meaning set forth in Section 15.8(b)(iv)(C) hereof. 

“Participant” means any Eligible Person who holds an outstanding Award or Common Stock acquired pursuant to an Award granted
under the Plan. 
 “Payment” shall have the meaning set forth in Section 15.8(b)(i) hereof. 

“Performance Award” shall mean an Award that vests, in whole or in part, based on the attainment of Performance Goals and
that are granted pursuant to Section 10 hereof. 
 “Performance Criteria” shall have the meaning set forth in
Section 10.2 hereof. 
 “Performance Goals” shall have the meaning set forth in Section 10.3 hereof. 

“Person” shall have the meaning ascribed to such term in Section 3(a)(9) of the Exchange Act and used in Sections 13(d)
and 14(d) thereof, including a “group” as defined in Section 13(d) thereof. 
 “Plan” means this Syneos
Health, Inc. 2018 Equity Incentive Plan, as may be amended from time to time. 
 “Policy” shall have the meaning set forth
in Section 13.3(b) hereof. 
 “Principal Market” means, as of any date of determination, the principal exchange on
which the Common Stock is then listed on such date. 
 “Prior Plan” means the INC Research Holdings, Inc. 2014 Equity
Incentive Plan, as amended from time to time. 
 “Reduced Amount” shall have the meaning set forth in
Section 15.8(b)(iv)(A) hereof. 
 “Restricted Stock Award” means a grant of shares of Common Stock to an Eligible
Person under Section 8 hereof that are issued subject to such vesting and transfer restrictions as the Committee shall determine, and such other conditions, in each case, as are set forth in the Plan and the applicable Award Agreement. 

“Restricted Stock Unit” means a contractual right granted to an Eligible Person under Section 9 hereof representing a
notional unit interest equal in value to a share of Common Stock to be paid or distributed at such times, and subject to such conditions, in each case, as set forth in the Plan and the applicable Award Agreement. 

“Service” means a Participant’s service with the Company or any Subsidiary as an employee, Non-Employee Director,
consultant or other service provider of the Company or any Subsidiary, as applicable. 
 “Share Reserve” shall have the
meaning set forth in Section 4.1 hereof. 
 “Stock Appreciation Right” means a contractual right granted to an
Eligible Person under Section 7 hereof entitling such Eligible Person to receive a payment, in cash and/or shares of Common Stock, representing the excess of the Fair Market Value of a share of Common Stock over the base price per share of the
right, at such time, and subject to such conditions, in each case, as are set forth in the Plan and the applicable Award Agreement. 

“Stock Award” means a grant of shares of Common Stock to an Eligible Person under Section 11 hereof that, pursuant to
the Unrestricted Pool, may be issued free of transfer restrictions and forfeiture conditions 

  
 3 

 “Stock Option” means a contractual right granted to an Eligible Person under
Section 6 hereof to purchase shares of Common Stock at such time and price, and subject to such conditions, in each case, as are set forth in the Plan and the applicable Award Agreement. 

“Subsidiary” means an entity (whether or not a corporation) that is wholly or majority owned or controlled, directly or
indirectly, by the Company or any other Affiliate of the Company that is so designated, from time to time, by the Committee, during the period of such Affiliated status; provided, however, that with respect to Incentive Stock Options,
the term “Subsidiary” shall include only an entity that qualifies under Section 424(f) of the Code as a “subsidiary corporation” with respect to the Company. 

“Successor Entity” shall have the meaning set forth in Section 12.4(b) hereof. 

“Tax-Related Items” means any U.S. federal, state, and/or local taxes and any taxes imposed by a jurisdiction outside the
U.S. (including, without limitation, income tax, social insurance and similar contributions, payroll tax, fringe benefits tax, payment on account, employment taxes, stamp tax and any other taxes related to participation in the Plan and legally
applicable to a Participant, including any employer liability for which the Participant is liable pursuant to applicable laws or the applicable Award Agreement). 

“Treasury Regulations” shall have the meaning set forth in Section 15.8 hereof. 

“Underpayment” shall have the meaning set forth in Section 15.8(b)(iii) hereof. 

“Unrestricted Pool” means a number of Shares equal to five percent (5%) of the number of shares of Common Stock that are
available for the grant of Awards hereunder as of the Effective Date, subject to adjustment as provided in Section 4.5 hereof. 

3.    Administration. 

3.1    Committee Members. The Plan shall be administered by a Committee comprised of no fewer than two members of
the Board who are appointed by the Board to administer the Plan. To the extent deemed necessary by the Board, or as may be required by any applicable securities or tax laws, the Principal Market, each Committee (as defined in clause (i) or (ii)
of the definition thereof) member shall satisfy the requirements for (i) an “independent director” under rules adopted by the Principal Market and (ii) a “nonemployee director” for purposes of Rule 16b-3 under the
Exchange Act. Notwithstanding the foregoing, the mere fact that a Committee (as defined in clause (i) or (ii) of the definition thereof) member shall fail to qualify under any of the foregoing requirements shall not invalidate any Award made by
the Committee (as defined in clause (i) or (ii) of the definition thereof) which Award is otherwise validly made under the Plan. Neither the Company nor any member of the Committee shall be liable for any action or determination made in
good faith by the Committee with respect to the Plan or any Award thereunder. The Board shall have the authority to execute the powers of the Committee under the Plan. 

3.2    Committee Authority. The Committee shall have all powers and discretion necessary or appropriate to
administer the Plan and to control its operation, including, but not limited to, the power to (i) determine the Eligible Persons to whom Awards shall be granted under the Plan and to grant Awards, (ii) prescribe the restrictions, terms and
conditions of all Awards and shares of Common Stock issued pursuant to Awards subject to this Plan, (iii) interpret the Plan and terms of the Awards, (iv) adopt rules for the administration, interpretation and application of the Plan as
are consistent therewith, and interpret, amend or revoke any such rules, (v) make all determinations with respect to a Participant’s Service and the termination of such Service for purposes of any Award, (vi) subject the provisions of
Section 6 hereof, to extend at any time the period in which Stock Options may be exercised, (vii) to determine at any time whether, to what extent, and under what circumstances distribution or the receipt of Stock and other amounts payable
with respect to an Award shall be deferred either automatically or at the election of the receiving Participant and whether and to what extent the Company shall pay or credit amounts constituting interest (at rates determined by the Committee) or
dividends or deemed dividends on such deferrals, (viii) correct any defect(s) 

  
 4 

 
or omission(s) or reconcile any ambiguity(ies) or inconsistency(ies) in the Plan or any Award thereunder, (ix) make all determinations it deems advisable for the administration of the Plan,
decide all disputes arising in connection with the Plan, and otherwise supervise the administration of the Plan, (x) suspend the right to exercise or net exercise any Award during any blackout period that is necessary or desirable to comply
with the requirements of applicable securities or exchange control laws, and extend the period for exercise of such Award by an equal period of time, (xi) subject to the terms of the Plan, amend the terms of an Award in any manner that is not
inconsistent with the Plan, and (xii) adopt such procedures, subplans and Award Agreements as are necessary or appropriate to facilitate participation in the Plan by Eligible Persons who are foreign nationals or employed outside of the United
States or as otherwise are necessary or appropriate for the administration and application of the Plan. The Committee’s determinations under the Plan need not be uniform and may be made by the Committee selectively among Participants and
Eligible Persons, whether or not such persons are similarly situated. The Committee shall, in its discretion, consider such factors as it deems relevant in making its interpretations, determinations and actions under the Plan including, without
limitation, the recommendations or advice of any officer or employee of the Company or such attorneys, consultants, accountants or other advisors as it may select. All interpretations, determinations and actions by the Committee shall be final,
conclusive and binding upon all parties. 
 3.3    Delegation of Authority. The Committee shall have the right,
from time to time, to delegate to one or more officers of the Company the authority of the Committee to grant and determine the terms and conditions of Awards granted under the Plan, subject to the requirements of Section 157(c) of the Delaware
General Corporation Law (or any successor provision) and such other limitations as the Committee shall determine. In no event shall any such delegation of authority be permitted with respect to Awards granted to any member of the Board or to any
Eligible Person who is subject to Rule 16b-3 under the Exchange Act (as determined in accordance with applicable guidance as of the applicable date of determination). The Committee shall also be permitted to delegate, to any appropriate officer or
employee of the Company, responsibility for performing certain ministerial functions under the Plan. In the event that the Committee’s authority is delegated to officers or employees in accordance with the foregoing, all provisions of the Plan
relating to the Committee shall be interpreted in a manner consistent with the foregoing by treating any such reference as a reference to such officer or employee for such purpose. Any action undertaken in accordance with the Committee’s
delegation of authority hereunder shall have the same force and effect as if such action was undertaken directly by the Committee and shall be deemed for all purposes of the Plan to have been taken by the Committee. 

4.    Shares Subject to the Plan. 

4.1    Number of Shares Reserved. Subject to adjustment as provided in Section 4.5 hereof and subject to
Section 15.10 hereof, the total number of shares of Common Stock that are reserved for issuance under the Plan shall be the sum of (i) 5,230,000 shares of Common Stock, plus (ii) the number of shares of Common Stock available for
issuance under the Prior Plan, as of the Effective Date (including shares of Common Stock subject to awards granted under the Prior Plan that would otherwise subsequently become available for issuance under the Prior Plan upon forfeiture,
cancellation, termination or any other reason under the terms of the Prior Plan) (the “Share Reserve”). The total number of shares of Common Stock that may be issued pursuant to Incentive Stock Options shall be 5,230,000,
subject to adjustment as provided in Section 4.5 hereof and the provisions of Sections 422 or 424 of the Code and any successor provisions. Each share of Common Stock subject to an Award shall reduce the Share Reserve by one share;
provided, that Awards that are required to be paid in cash pursuant to their terms shall not reduce the Share Reserve. Any shares of Common Stock delivered under the Plan shall consist of authorized and unissued shares, treasury shares, or
shares purchased on the open market. 
 4.2    Share Replenishment. To the extent that an Award granted under
this Plan is cancelled, expired, forfeited, surrendered, settled by delivery of fewer shares than the number underlying the Award, settled in cash or otherwise terminated without delivery of the shares to the Participant, the shares of Common Stock
retained by or returned to the Company will (i) not be deemed to have been delivered under the Plan, (ii) be available for future Awards under the Plan, and (iii) increase the Share Reserve by one share for each share that is retained
by or returned 

  
 5 

 
to the Company; provided, that notwithstanding the foregoing, shares that are (x) withheld from an Award or separately surrendered by the Participant in payment of the exercise or
purchase price or Tax-Related Items with respect to such an Award, (y) not issued or delivered as a result of the net settlement of an outstanding Stock Option or Stock Appreciation Right or (z) repurchased on the open market using
proceeds from the exercise of a Stock Option shall be deemed to constitute delivered shares, shall count against the Share Reserve and shall not be available for future Awards under the Plan and shall continue to be counted as outstanding for
purposes of determining whether any of the Award limits specified in Sections 4.3 or 4.4 have been attained. 

4.3    Awards Granted to Eligible Persons Other Than Non-Employee Directors. The maximum number of shares of Common
Stock that may be subject to (i) Stock Options, (ii) Stock Appreciation Rights, (iii) Restricted Stock Awards that vest in full or in part based on the attainment of Performance Goals and (iv) Restricted Stock Units that vest in
full or in part based on the attainment of Performance Goals that are granted to any Eligible Person other than a Non- Employee Director during any calendar year shall be limited to 2,000,000 shares of Common
Stock for each such Award type individually (subject to adjustment as provided in Section 4.5 hereof). 

4.4    Awards Granted to Non-Employee Directors. Notwithstanding any provision to the contrary in the Plan or in
any policy of the Company regarding compensation payable to a Non-Employee Director, the sum of the grant date fair value (determined as of the grant date in accordance with Financial Accounting Standards
Board Accounting Standards Codification Topic 718, or any successor thereto) of all Awards payable in shares of Common Stock, and the maximum amount that may become payable with respect to all cash-settled Awards that may be granted under the Plan
to an individual as compensation for services as a Non-Employee Director, together with cash compensation paid to the Non-Employee Director, shall not exceed $500,000 in
any calendar year; provided, however, that if such Non-Employee Director is the Chairman of the Board, such amount shall not exceed $800,000 in any calendar year. 

4.5    Adjustments. If there shall occur any change with respect to the outstanding shares of Common Stock by
reason of any recapitalization, reclassification, stock dividend, extraordinary dividend, stock split, reverse stock split or other distribution with respect to the shares of Common Stock or any merger, reorganization, consolidation, combination,
spin-off, stock purchase or other similar corporate change or any other change affecting the Common Stock (other than regular cash dividends to stockholders of the Company), the Committee shall, in the manner and to the extent it considers equitable
to the Participants and consistent with the terms of the Plan, (i) cause an adjustment to be made to the maximum number and kind of securities pursuant to Sections 4.1 (including the maximum number of shares of Common Stock that may be issued
pursuant to Incentive Stock Options) and 4.3 hereof (including the maximum number of shares of Common Stock that may become payable to a Participant pursuant to Section 4.3 hereof and the number of shares of Common Stock in the Unrestricted
Pool), (ii) cause an adjustment to be made to the number and kind of securities, units or other rights subject to then outstanding Awards, (iii) cause an adjustment to be made to the exercise or base price for each share or unit or other right
subject to then outstanding Awards, (iv) issue additional Awards or shares of Common Stock, issue dividend equivalent rights or make cash payments to the holders of outstanding Awards, in each case, on such terms and conditions as determined by
the Committee, and/or (v) cause an adjustment to be made to any other terms of an Award that are affected by the event. Notwithstanding the foregoing, (a) any such adjustments shall, to the extent necessary, be made in a manner consistent
with the requirements of Section 409A of the Code, and (b) in the case of Incentive Stock Options, any such adjustments shall, to the extent practicable, be made in a manner consistent with the requirements of Section 424(a) of the
Code. 
 5.    Eligibility and Awards. 

5.1    Designation of Participants. Any Eligible Person may be selected by the Committee to receive an Award and
become a Participant under the Plan. The Committee has the authority, in its discretion, to determine and designate from time to time those Eligible Persons who are to be granted Awards, the types of Awards to be granted, the number of shares of
Common Stock or units subject to Awards to be granted, the terms and conditions of such 

  
 6 

 
Awards consistent with the terms of the Plan, and to grant any such Awards. In selecting Eligible Persons to be Participants, and in determining the type and amount of Awards to be granted under
the Plan, the Committee shall consider any and all factors that it deems relevant or appropriate. Designation of a Participant in any year shall not require the Committee to designate such person to receive an Award in any other year or, once
designated, to receive the same type or amount of Award as granted to the Participant in any other year. 

5.2    Determination of Awards. The Committee shall determine the terms and conditions of all Awards granted to
Participants in accordance with its authority under Section 3.2 hereof. An Award may consist of one type of right or benefit hereunder or of two or more such rights or benefits granted in tandem. 

5.3    Award Agreements. Each Award granted to an Eligible Person under the Plan shall be represented by an Award
Agreement. The terms of all Awards under the Plan, as determined by the Committee, will be set forth in each individual Award Agreement as described in Section 15.2 hereof. 

5.4    Corporate Action Constituting Grant of Awards. Corporate action constituting a grant by the Company of an
Award to any Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Committee in the resolutions comprising such corporate action, regardless of when the instrument, certificate or letter
evidencing the Award is communicated to, or actually received or accepted by, the Participant. In the event that the corporate records (e.g., Committee consents, resolutions or minutes) documenting the corporate action constituting the Award grant
contain terms (e.g., exercise price, vesting schedule or number of shares) that are inconsistent with those in the Award Agreement or related grant documents as a result of a clerical error in the papering of the Award Agreement or related grant
documents, the corporate records will control and the Participant will have no legally binding right to the incorrect term in the Award Agreement or related grant documents. 

5.5    Minimum Vesting Requirements. Except for substitute Awards as set forth in Section 15.10 hereof, Awards
relating to shares of Common Stock in the Unrestricted Pool, Awards granted under the Plan on or after the Effective Date shall vest no earlier than the one (1) year anniversary of the Date of Grant; provided, however, that the Committee, in
its sole discretion, may accelerate the vesting or exercisability of an Award upon a Change in Control in accordance with Section 12.3 hereof, or upon a Participant’s death or Disability, in each case, as set forth in the Award Agreement
or the Committee’s subsequent resolutions. The Committee may accelerate the vesting or exercisability of an Award in circumstances other than a Change in Control or a Participant’s death or Disability, in each case, as set forth in the
Award Agreement or the Committee’s subsequent resolutions, provided that such acceleration does not cause an Award that is subject to this Section 5.5 to vest or become exercisable prior to the first anniversary of the Date of Grant. 

6.    Stock Options. 

6.1    Grant of Stock Options. A Stock Option may be granted to any Eligible Person selected by the Committee,
except that an Incentive Stock Option may only be granted to an Eligible Person satisfying the conditions of Section 6.7(a) hereof. Each Stock Option shall be designated on the Date of Grant, in the discretion of the Committee, as an Incentive
Stock Option or as a Nonqualified Stock Option. 
 6.2    Exercise Price. The exercise price per share of a Stock
Option shall not be less than one hundred percent (100%) of the Fair Market Value of a share of Common Stock on the Date of Grant. The Committee may in its discretion specify an exercise price per share that is higher than the Fair Market Value of a
share of Common Stock on the Date of Grant. 
 6.3    Vesting of Stock Options. Subject to Section 5.5
hereof, the Committee shall, in its discretion, prescribe the time or times at which or the conditions upon which a Stock Option or portion thereof shall become vested and/or exercisable. The requirements for vesting and exercisability of a Stock
Option may be based on the continued Service of the Participant with the Company or a Subsidiary for a specified time period (or periods), on the 

  
 7 

 
attainment of a specified performance conditions or on such other terms and conditions as approved by the Committee in its discretion, all as set forth in the Award Agreement. If the vesting
requirements of a Stock Option are not satisfied, the Award shall be forfeited as set forth in the Award Agreement. 

6.4    Term of Stock Options. The Committee shall in its discretion prescribe in an Award Agreement the period
during which a vested Stock Option may be exercised; provided, however, that the maximum term of a Stock Option shall be ten (10) years from the Date of Grant. The Committee may provide that a Stock Option will cease to be exercisable upon or
at the end of a specified time period following a termination of Service for any reason as set forth in the Award Agreement or otherwise. 

6.5    Stock Option Exercise; Tax Withholding. Subject to such terms and conditions as specified in an Award
Agreement, a Stock Option may be exercised in whole or in part at any time during the term thereof by notice in the form required by the Company, together with payment of the aggregate exercise price and applicable Tax-Related Items withholding.
Payment of the exercise price shall be made: (i) in cash or by cash equivalent acceptable to the Committee or (ii) to the extent permitted by the Committee in its sole discretion and set forth in the Award Agreement or otherwise (including
by a policy or resolution of the Committee), (A) in shares of Common Stock valued at the Fair Market Value of such shares on the date of exercise, (B) through an open-market, broker-assisted sales transaction pursuant to which the Company is
promptly delivered the amount of proceeds necessary to satisfy the exercise price, (C) by reducing the number of shares of Common Stock otherwise deliverable upon the exercise of the Stock Option by the number of shares of Common Stock having a
Fair Market Value on the date of exercise equal to the exercise price, (D) by a combination of the methods described above or (E) by such other method as may be approved by the Committee and set forth in the Award Agreement. In addition to
and at the time of the applicable taxable event, the Participant shall pay to the Company the full amount of any and all applicable Tax- Related Items required to be withheld in connection with the Option (including, such exercise), payable by such
of the methods described above for the payment of the exercise price as may be approved by the Committee and set forth in the Award Agreement. 

6.6    Limited Transferability of Nonqualified Stock Options. All Nonqualified Stock Options shall be exercisable
during the Participant’s lifetime only by the Participant or by the Participant’s guardian or legal representative. The Nonqualified Stock Options and the rights and privileges conferred thereby shall be non-transferable, except as
otherwise provided in Section 15.3 hereof. 
 6.7    Additional Rules for Incentive Stock Options. 

(a)    Eligibility. An Incentive Stock Option may only be granted to an Eligible Person who is considered an
employee for purposes of Treasury Regulation § 1.421-1(h) with respect to the Company or any Subsidiary that qualifies as a “subsidiary corporation” with respect to the Company for purposes of Section 424(f) of the Code. 

(b)    Annual Limits. No Incentive Stock Option shall be granted to a Participant as a result of which the
aggregate Fair Market Value (determined as of the Date of Grant) of the Common Stock with respect to which incentive stock options under Section 422 of the Code are exercisable for the first time in any calendar year under the Plan and any
other stock option plans of the Company or any subsidiary or parent corporation would exceed $100,000, determined in accordance with Section 422(d) of the Code. This limitation shall be applied by taking such incentive stock options into
account in the order in which they were granted. 
 (c)    Additional Limitations. In the case of any Incentive
Stock Option granted to an Eligible Person who owns, either directly or indirectly (taking into account the attribution rules contained in Section 424(d) of the Code), stock possessing more than ten percent (10%) of the total combined voting
power of all classes of stock of the Company or any Subsidiary, the exercise price shall not be less than one hundred ten percent (110%) of the Fair Market Value of a share of Common Stock on the Date of Grant and the maximum term shall be five
(5) years. 

  
 8 

 (d)    Termination of Employment. An Award of an Incentive Stock
Option shall provide that such Stock Option may be exercised not later than (i) three (3) months following termination of employment of the Participant with the Company and all Subsidiaries (other than as set forth in clause (ii) of this
Section 6.7(d)) or (ii) one year following termination of employment of the Participant with the Company and all Subsidiaries due to death or permanent and total disability within the meaning of Section 22(e)(3) of the Code, in each
case as and to the extent determined by the Committee to comply with the requirements of Section 422 of the Code. 

(e)    Other Terms and Conditions; Nontransferability. No Incentive Stock Options granted under the Plan may be
granted more than ten (10) years following the date that the Plan is adopted or the date the Plan is approved by the Company’s stockholders, whichever is earlier. The Award Agreement representing any Incentive Stock Option granted
hereunder shall contain such additional terms and conditions, not inconsistent with the terms of the Plan, as are deemed necessary or desirable by the Committee, which terms, together with the terms of the Plan, shall be intended and interpreted to
cause such Incentive Stock Option to qualify as an “incentive stock option” under Section 422 of the Code. A Stock Option that is granted as an Incentive Stock Option shall, to the extent it fails to qualify as an “incentive
stock option” under the Code, be treated as a Nonqualified Stock Option. An Incentive Stock Option shall by its terms be nontransferable other than by will or by the laws of descent and distribution, and shall be exercisable during the lifetime
of a Participant only by such Participant. 
 (f)    Disqualifying Dispositions. If shares of Common Stock
acquired by exercise of an Incentive Stock Option are disposed of within two years following the Date of Grant or one year following the transfer of such shares to the Participant upon exercise, the Participant shall, promptly following such
disposition, notify the Company in writing of the date and terms of such disposition and provide such other information regarding the disposition as the Company may reasonably require. 

7.    Stock Appreciation Rights. 

7.1    Grant of Stock Appreciation Rights. Stock Appreciation Rights may be granted to any Eligible Person selected
by the Committee. Stock Appreciation Rights may be granted on a basis that allows for the exercise of the right by the Participant or that provides for the automatic payment of the right upon a specified date or event, in either case, as set forth
in the Award Agreement representing such Stock Appreciation Rights. Stock Appreciation Rights and the rights and privileges conferred thereby shall be non-transferable, except as provided in Section 15.3 hereof. 

7.2    Stand-Alone Stock Appreciation Rights. A Stock Appreciation Right may be granted without any related Stock
Option. Subject to Section 5.5 hereof, the Committee shall in its discretion provide in an Award Agreement the time or times at which or the conditions upon which a Stock Appreciation Right or portion thereof shall become vested and/or
exercisable. The requirements for vesting and exercisability of a Stock Appreciation Right may be based on the continued Service of a Participant with the Company or a Subsidiary for a specified time period (or periods), on the attainment of a
specified performance conditions or on such other terms and conditions as approved by the Committee in its discretion, all as set forth in the Award Agreement. If the vesting requirements of a Stock Appreciation Right are not satisfied, the Award
shall be forfeited as set forth in the Award Agreement. A Stock Appreciation Right will be exercisable or payable at such time or times as determined by the Committee as set forth in the Award Agreement; provided, that the maximum term of a
Stock Appreciation Right shall be ten (10) years from the Date of Grant. The Committee may provide that a Stock Appreciation Right will cease to be exercisable upon or at the end of a period following a termination of Service for any reason as
set forth in the Award Agreement. The base price of a Stock Appreciation Right granted without any related Stock Option shall be determined by the Committee in its discretion; provided, however, that the base price per share of any
such stand-alone Stock Appreciation Right shall not be less than one hundred percent (100%) of the Fair Market Value of a share of Common Stock on the Date of Grant. 

  
 9 

 7.3    Tandem Stock Option/Stock Appreciation Rights. A Stock
Appreciation Right may be granted in tandem with a Stock Option and constitute a single Award. A tandem Stock Option/Stock Appreciation Right will entitle the holder to elect, as to all or any portion of the number of shares subject to the Award, to
exercise either the Stock Option or the Stock Appreciation Right, resulting in the reduction of the corresponding number of shares subject to the Award, including the tandem Stock Appreciation Right or Stock Option, as applicable, not so exercised.
A Stock Appreciation Right granted in tandem with a Stock Option hereunder shall have a base price per share equal to the per share exercise price of the Stock Option, will be vested and exercisable at the same time or times that a related Stock
Option is vested and exercisable, and will expire no later than the time at which the related Stock Option expires, in each case, as set forth in the Award Agreement. 

7.4    Payment of Stock Appreciation Rights. A Stock Appreciation Right will entitle the holder, upon exercise or
other payment of the Stock Appreciation Right, as applicable, to receive an amount determined by multiplying: (i) the excess of the Fair Market Value of a share of Common Stock on the date of exercise or payment of the Stock Appreciation Right
over the base price of such Stock Appreciation Right, by (ii) the number of shares as to which such Stock Appreciation Right is exercised or paid. Payment of the amount determined under the foregoing may be made, as approved by the Committee
and set forth in the Award Agreement, in shares of Common Stock valued at their Fair Market Value on the date of exercise or payment, in cash or in a combination of shares of Common Stock and cash, subject to applicable Tax- Related Items
withholding requirements. 
 8.    Restricted Stock Awards. 

8.1    Grant of Restricted Stock Awards. A Restricted Stock Award may be granted to any Eligible Person selected by
the Committee. The Committee may require the payment by the Participant of a specified purchase price in connection with the issuance of any Restricted Stock Award as set forth in the Award Agreement representing such Restricted Stock Award, which
may also include the manner in which payment of any specified purchase price may be made as prescribed by the Committee. 

8.2    Vesting Requirements. The restrictions imposed on shares granted under a Restricted Stock Award shall lapse
in accordance with the vesting requirements specified by the Committee in the Award Agreement. Subject to Section 5.5 hereof, the requirements for vesting of a Restricted Stock Award may be based on the continued Service of the Participant with
the Company or a Subsidiary for a specified time period (or periods), on the attainment of a specified Performance Goals or on such other terms and conditions as approved by the Committee in its discretion. If the vesting requirements of a
Restricted Stock Award shall not be satisfied or, if applicable, the Performance Goals with respect to such Restricted Stock Award are not attained, the Award shall be forfeited and the shares of Stock subject to the Award shall be returned to the
Company, as set forth in the Award Agreement. 
 8.3    Transfer Restrictions. Shares granted under any
Restricted Stock Award and the rights and privileges conferred thereby shall be non- transferable until all applicable restrictions are removed or have expired, except as provided in Section 15.3 hereof. Failure to satisfy any applicable
restrictions shall result in the subject shares of the Restricted Stock Award being forfeited and returned to the Company. The Committee may require in an Award Agreement that certificates (if any) representing the shares granted under a Restricted
Stock Award bear a legend making appropriate reference to the restrictions imposed, and that certificates (if any) representing the shares granted or sold under a Restricted Stock Award will remain in the physical custody of an escrow holder (which
may be the Company or an officer of the Company) until all restrictions are removed or have expired. 
 8.4    Rights
as Stockholder. Subject to the provisions of Section 15.6 hereof, any dividends that are distributed with respect to Restricted Stock shall be paid in accordance with the applicable Award Agreement. 

8.5    Section 83(b) Election. If a Participant makes an election pursuant to Section 83(b) of the Code with
respect to a Restricted Stock Award, the Participant shall file, within thirty (30) days following the Date of Grant, a copy of such election with the Company and with the Internal Revenue Service, in accordance with the regulations under
Section 83 of the Code. The Committee may provide in an Award Agreement that the Restricted Stock Award is conditioned upon the Participant’s making or refraining from making an election with respect to the Award under Section 83(b)
of the Code. 

  
 10 

 9.    Restricted Stock Units. 

9.1    Grant of Restricted Stock Units. A Restricted Stock Unit may be granted to any Eligible Person selected by
the Committee. The value of each Restricted Stock Unit shall be equal to the Fair Market Value of the Common Stock on the applicable date or time period of determination, as specified by the Committee. Restricted Stock Units shall be subject to such
restrictions and conditions as the Committee shall determine and as set forth in the Award Agreement representing such Restricted Stock Units. Restricted Stock Units and the rights and privileges conferred thereby shall be non-transferable, except
as provided in Section 15.3 hereof. 
 9.2    Vesting of Restricted Stock Units. Subject to Section 5.5
hereof, on the Date of Grant, the Committee shall, in its discretion, determine any vesting requirements with respect to Restricted Stock Units, which shall be set forth in the Award Agreement. The requirements for vesting of a Restricted Stock Unit
may be based on the continued Service of the Participant with the Company or a Subsidiary for a specified time period (or periods), on the attainment of Performance Goals or on such other terms and conditions as approved by the Committee in its
discretion. If the vesting requirements of a Restricted Stock Units Award are not satisfied or, if applicable, the Performance Goals with respect to such Restricted Stock Units Award are not attained, the Award shall be forfeited, as set forth in
the Award Agreement. 
 9.3    Payment of Restricted Stock Units. Restricted Stock Units shall become payable to
a Participant at the time or times determined by the Committee and set forth in the Award Agreement, which may be upon or following the vesting of the Award. Payment of a Restricted Stock Unit may be made, as approved by the Committee and set forth
in the Award Agreement, in cash or in shares of Common Stock or in a combination thereof, subject to applicable Tax-Related Items withholding requirements. Any cash payment of a Restricted Stock Unit shall be made based upon the Fair Market Value of
the Common Stock, determined on such date or over such time period as determined by the Committee and set forth in the Award Agreement. 

9.4    Dividend Equivalent Rights. Restricted Stock Units may be granted together with a dividend equivalent right
with respect to the shares of Common Stock subject to the Award, which dividend equivalent rights may be deemed reinvested in additional Restricted Stock Units or may be accumulated in cash, as determined by the Committee in its discretion and set
forth in an Award Agreement. To the extent dividend equivalent rights are granted in connection with a Restricted Stock Unit, the dividend equivalent rights will be accumulated and subject to the restrictions and risk of forfeiture to the same
extent as the underlying Restricted Stock Unit. 
 9.5    No Rights or a Stockholder. The Participant shall not
have any rights or be a stockholder with respect to the shares subject to a Restricted Stock Unit until such time as shares of Common Stock are delivered to the Participant pursuant to the terms of the Award Agreement. 

10.    Performance Awards and Performance Criteria. 

10.1    Establishment of Performance-Based Terms. The Committee may grant Awards that vest, in whole or in part,
based on Performance Goals (“Performance Awards”). The Committee will determine with respect to Performance Award the duration of the performance period, the Performance Criteria, the applicable Performance Goals relating to the
Performance Criteria and the amount and terms of payment/vesting upon achievement of the Performance Goals. 

10.2    Performance Criteria. For purposes of Performance Awards, the “Performance Criteria” shall
include, but are not limited to, any one or more of the following, for the Company or any identified Subsidiary, division or business unit or line, as determined by the Committee at the time of the Award: (i) total stockholder return;
(ii) such total stockholder return as compared to total return (on a comparable basis) of a publicly available index 

  
 11 

 
such as, but not limited to, the Standard & Poor’s 500 Stock Index; (iii) net income; (iv) pretax earnings; (v) adjusted net income; (vi) adjusted pretax
earnings; (vii) adjusted earnings per share; (viii) adjusted earnings before interest expense, taxes, depreciation and amortization (“EBITDA”); (ix) pretax operating earnings after interest expense and before bonuses,
service fees, and extraordinary or special items; (x) operating margin; (xi) earnings per share; (xii) return on equity; (xiii) return on capital; (xiv) return on investment; (xv) operating earnings; (xvi) working
capital; (xvii) ratio of debt to stockholders’ equity; (xviii) revenue; (xix) free cash flow (i.e., EBITDA, less cash taxes, cash interest, net capital expenditures, mandatory payments of principal under any credit facility and
payments under collateralized lease obligations and financing lease obligations); and (xx) any combination of or a specified increase in any of the foregoing. 

10.3    Performance Goals. For purposes of Performance Awards, the “Performance Goals” shall be
the levels of achievement relating to the Performance Criteria selected by the Committee for the Award. The Performance Goals may be applied on an absolute basis or relative to an identified index, peer group or one or more competitors or other
companies (including particular business segments or divisions of such companies), as specified by the Committee. The Performance Goals need not be the same for all Participants. 

10.4    Adjustments. At the time that an Award is granted, the Committee may provide for the Performance Goals or
the manner in which performance will be measured against the Performance Goals to be adjusted in such objective manner as it deems appropriate, including, without limitation, adjustments to reflect non-cash losses or charges (e.g., amortization
expense, stock-based compensation, impairments, etc.), charges for restructurings, non-operating income, the impact of corporate transactions, discontinued operations or financing transactions, severance and recruitment costs, “run rate”
savings, costs incurred in establishing new manufacturing sources, specified legal expenses, extraordinary and other unusual or non-recurring items or events and the cumulative effects of accounting or tax law
changes. In addition, with respect to a Participant hired or promoted following the beginning of a performance period, the Committee may determine to prorate the Performance Goals and/or the amount of any payment in respect of such
Participant’s Performance Awards for the partial performance period. 
 11.    Stock Awards. 

11.1    Grant of Stock Awards. A Stock Award may be granted to any Eligible Person selected by the Committee. A
Stock Award may be granted for past, or in anticipation of future, Services, in lieu of any discretionary bonus or other discretionary cash compensation, as directors’ compensation or for any other valid purpose as determined by the Committee.
Subject to Section 5.5 hereof, the Committee shall determine the terms and conditions of such Awards, including any applicable requirements for vesting of a Stock Award which may be based on the continued Service of the Participant with the
Company or a Subsidiary for a specified time period (or periods) or on such other terms and conditions as approved by the Committee in its discretion. Stock Awards relating to shares of Common Stock in the Unrestricted Pool shall be made without
vesting requirements. In addition, the Committee may, in connection with any Stock Award, require the payment of a specified purchase price, which may also include the manner in which payment of any specified purchase price may be made as prescribed
by the Committee. 
 11.2    Rights as Stockholder. Subject to the foregoing provisions of this Section 11
and the applicable Award Agreement, upon the issuance of the Common Stock under a Stock Award, the Participant shall have all rights of a stockholder with respect to the shares of Common Stock, including the right to vote the shares and, subject to
Section 15.6, receive all dividends and other distributions paid or made with respect thereto. 

11.3    Elections to Receive Stock in Lieu of Compensation. Subject to Section 409A of the Code and, if
applicable, Section 15.4 hereof, upon the request of a Participant who is a U.S. taxpayer and with the consent of the Committee, such Participant may, pursuant to an advance written election delivered to the Company no later than the date
specified by the Committee, receive a portion of the cash compensation otherwise due to such Participant in the form of shares of Common Stock either currently or on a deferred basis in accordance with Section 15.4 hereof. 

  
 12 

 11.4    Restrictions on Transfers. The right to receive shares of
Common Stock on a deferred basis and the rights and privileges conferred thereby shall be non-transferable, except as provided in Section 15.3 hereof. 

12.    Change in Control. 

12.1    Effect on Awards other than Performance Awards. Upon the occurrence of a Change in Control, except as set
forth in Section 12.2 below: (i) if a Participant’s Awards are not converted, assumed, substituted or replaced by a successor or survivor corporation, or a parent or subsidiary thereof, then in connection with such Change in Control
such Awards shall become fully exercisable and all forfeiture restrictions on such Awards shall lapse; and (ii) if an employee Participant’s Awards are converted, assumed, substituted or replaced by a successor or survivor corporation, or
a parent or subsidiary thereof after a Change in Control, the vesting of the Awards will automatically accelerate upon an involuntary termination of the Participant’s employment by the Company or a Subsidiary without Cause or Participant’s
resignation for Good Reason (as defined in the applicable Award Agreement) within the period designated in the applicable Award Agreement following the effective date of such Change in Control, and accordingly, all such Awards shall become fully
exercisable and all forfeiture restrictions on the Awards shall lapse. In the event that the terms of any agreement (other than the Award Agreement) between the Company or any Subsidiary and a Participant contains provisions that conflict with and
are more restrictive than the provisions of this Section 12.1, this Section 12.1 shall prevail and control and the more restrictive terms of such agreement (and only such terms) shall be of no force or effect. 

12.2    Effect on Performance Awards. In the event of a Change in Control, the vesting and payout of Performance
Awards shall be as provided in the Award Agreement or in such other written agreement entered into between the Company and a Participant. 

12.3    Further Adjustments. Subject to Section 12.1, unless otherwise provided in the Award Agreement, upon
the occurrence of a Change in Control, the Committee is authorized (but not obligated) to take such further action as it determines to be necessary or advisable, and fair and equitable to the Participants, with respect to outstanding Awards,
including, without limitation, any of the following (or any combination thereof): 
 (a)    continuation or assumption
of such outstanding Awards under the Plan by the Company (if it is the surviving company or corporation) or by the surviving company or corporation or its parent; 

(b)    substitution by the surviving company or corporation or its parent of awards with substantially the same or
comparable terms (including with respect to economic value) for outstanding Awards (with appropriate adjustments to the type of consideration payable upon settlement of the Awards); 

(c)    accelerated exercisability, vesting and/or payment under outstanding Awards immediately prior to or upon the
occurrence of such event or upon a termination of employment following such event; and 
 (d)    if all or substantially
all of the Company’s outstanding shares of Common Stock are transferred in exchange for cash consideration in connection with such Change in Control: 

(i)    upon written notice, provide that any outstanding Stock Options and Stock Appreciation Rights are exercisable
during a reasonable period of time immediately prior to the scheduled consummation of the event or such other reasonable period as determined by the Committee (contingent upon the consummation of the event), and at the end of such period, such Stock
Options and Stock Appreciation Rights shall terminate to the extent not so exercised within the relevant period; and 

(ii)    cancellation of all or any portion of outstanding Awards for fair value (in the form of cash, shares, other
property or any combination thereof) as determined in the sole discretion of the Committee; provided, that in the case of Stock Options and Stock Appreciation Rights, the fair value may equal the excess, if any, of the value of the
consideration to be paid in the Change in Control transaction to holders of the same number of 

  
 13 

 
shares of Common Stock subject to such Awards (or, if no such consideration is paid, Fair Market Value of the shares of Common Stock subject to such outstanding Awards or portion thereof being
canceled) over the aggregate exercise or base price, as applicable, with respect to such Awards or portion thereof being canceled, or, if there is no such excess, zero. 

12.4    Definition of Change in Control. Unless otherwise defined in an Award Agreement, “Change in
Control” shall mean the occurrence of one of the following events: 
 (a)    Any Person becomes the Beneficial
Owner, directly or indirectly, of more than fifty percent (50%) of the combined voting power, excluding any Person who Beneficially Owns fifty percent (50%) or more of the voting power on the Effective Date of the Plan, of the then outstanding
voting securities of the Company entitled to vote generally in the election of its directors (the “Outstanding Company Voting Securities”), including by way of merger, consolidation or otherwise; provided, however,
that for purposes of this definition, the following acquisitions shall not constitute a Change in Control: (i) any acquisition of Outstanding Company Voting Securities directly from the Company, including, without limitation, a public offering
of securities or (ii) any acquisition of Outstanding Company Voting Securities by the Company or any of its Subsidiaries, including an acquisition by any employee benefit plan or related trust sponsored or maintained by the Company or any of
its Subsidiaries. 
 (b)    Consummation of a reorganization, merger, or consolidation to which the Company is a party
or a sale or other disposition of all or substantially all of the assets of the Company (a “Business Combination”), unless, following such Business Combination: (i) any Persons who were the Beneficial Owners of Outstanding
Company Voting Securities immediately prior to such Business Combination are the Beneficial Owners, directly or indirectly, of more than fifty percent (50%) of the combined voting power of the outstanding voting securities entitled to vote generally
in the election of directors (or election of members of a comparable governing body) of the entity resulting from the Business Combination (including, without limitation, an entity which, as a result of such transaction, owns all or substantially
all of the Company or all or substantially all of the Company’s assets, either directly or through one or more subsidiaries) (the “Successor Entity”) in substantially the same proportions as their ownership immediately prior to
such Business Combination; or (ii) no Person (excluding any Successor Entity or any employee benefit plan or related trust of the Company, any of its Subsidiaries, such Successor Entity or any of its subsidiaries) is the Beneficial Owner,
directly or indirectly, of more than fifty percent (50%) of the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors (or comparable governing body) of the Successor Entity, except to
the extent that such ownership of the Company existed prior to the Business Combination. 
 (c)    Approval by the
stockholders of the Company of a complete liquidation or dissolution of the Company. 
 A transaction shall not constitute a Change in Control if it is
effected for the purpose of changing the place of incorporation, tax residency or form of organization of the ultimate parent entity (including where the ultimate parent entity is succeeded by an entity incorporated under the laws of another state,
country or foreign government for such purpose and whether or not the former ultimate parent entity remains in existence following such transaction) and where the shareholders of the Company immediately prior to any such transaction own (or continue
to own by remaining outstanding or by being converted into voting securities of the successor parent entity) more than 50% of the combined voting power of the former ultimate parent entity or the successor ultimate parent entity immediately
following such transaction, in substantially the same proportion to each other as prior to such transaction. 
 Notwithstanding the foregoing, to the extent
necessary to comply with Section 409A of the Code with respect to the payment of “nonqualified deferred compensation,” “Change of Control” shall be defined as, and limited to, a “change in control event” as defined
under Section 409A of the Code. 

  
 14 

 13.    Forfeiture Events. 

13.1    General. Notwithstanding anything contained herein to the contrary, all Awards shall be and remain subject
to any incentive compensation clawback or recoupment policy currently in effect, as may be amended from time to time, or any policy that may be adopted by the Board or Committee providing for the recovery of Awards, Shares, proceeds, or payments to
Participants in the event of a Participant’s fraud or misconduct or as required by applicable laws or to address governance considerations or in other similar circumstances. No such policy adoption or amendment shall in any event require the
prior consent of any Participant. The Committee also may specify in an Award Agreement at the time of the Award that the Participant’s rights, payments and benefits with respect to an Award shall be subject to reduction, cancellation,
forfeiture or recoupment upon the occurrence of certain specified events, in addition to any otherwise applicable vesting or performance conditions of an Award. Such events may include, but shall not be limited to, termination of Service for Cause,
violation of material Company policies, breach of noncompetition, confidentiality or other restrictive covenants that may apply to the Participant or other conduct by the Participant that is detrimental to the business or reputation of the Company
or one of its Subsidiaries. Notwithstanding anything to the contrary, no shares of Common Stock issued or issuable pursuant to Section 11.3 hereof shall be subject to this Section 13 hereof, other than Section 13.3 hereof or the terms
or as otherwise may be required pursuant to the terms and conditions of such cash compensation otherwise due to the Participant. 

13.2    Termination for Cause. 

(a)    Treatment of Awards. Unless otherwise provided by the Committee and set forth in an Award Agreement, if
(i) a Participant’s Service with the Company or any Subsidiary shall be terminated for Cause, or (ii) after termination of Service for any other reason, the Committee determines in its discretion, that the Participant engaged in
conduct that violates any continuing obligation or duty of the Participant set forth in any executive or restrictive covenant agreement with respect to non-competition, non-solicitation, confidentiality, intellectual property or trade secret
protection, or any similar agreement to which the Participant is a party in favor of the Company or any Subsidiary (any such event described in clause (i) or (ii), with respect to any Participant, shall be a “Forfeiture Event”
with respect to such Participant), then such Participant’s rights, payments and benefits with respect to such an Award shall be subject to cancellation, forfeiture and/or recoupment, as provided in Section 13.3 below. The Committee shall
have the power to determine whether, and the date on which, any Forfeiture Event has occurred and whether to exercise the right of recapture provided in Section 13.3. Any such determination shall be final, conclusive and binding upon the
Participant. In addition, if the Committee shall reasonably determine that a Forfeiture Event with respect to any Participant has occurred, then the Committee may suspend such Participant’s rights to exercise, receive any payment under or vest
in any right with respect to any Award pending a final determination by the Committee of whether such an act has been committed. 

(b)    Definition of Cause. Unless otherwise defined in an Award Agreement, “Cause” shall mean:

 (i)    if a Participant has an effective employment agreement, service agreement or other similar agreement with the
Company or any Subsidiary that defines “Cause” or a like term, the meaning set forth in such agreement at the time of the Participant’s termination of Service; or, 

(ii)    in the absence of such definition, (A) the Participant’s breach of any fiduciary duty or material
breach of any legal or contractual obligation to the Company or any of its Affiliates, or to the Company’s direct or indirect equity holders, (B) the Participant’s failure to follow the reasonable instructions of the Board or such
Participant’s direct supervisor, which breach, if curable, is not cured within ten (10) business days after notice to such Participant or, if cured, recurs within one hundred eighty (180) days, (C) the Participant’s gross
negligence, willful misconduct, fraud or acts of dishonesty relating to the Company or any of its Affiliates or (D) the Participant’s conviction of any misdemeanor relating to the affairs of the Company or any of its Affiliates or
indictment for any felony. 

  
 15 

 13.3    Right of Recapture. 

(a)    General. If a Forfeiture Event with respect to a Participant occurs at any time within one (1) year
(or such longer time period specified in any Award Agreement or other agreement with a Participant) after the date on which any Award to such Participant is exercised, vests, becomes payable or is paid or the date on which gain or income is
otherwise realized in connection with any such Award, then any gain or income realized by the Participant from the exercise, vesting, payment or other realization event in connection with such Award shall be paid by the Participant to the Company
upon written notice from the Company or the Committee, subject to applicable state or local law. Such gain or income shall be determined as of the date or dates on which such gain or income is realized by the Participant, without regard to any
subsequent change in the Fair Market Value of a share of Common Stock. The Company shall, subject to compliance with Section 409A of the Code and other applicable law, have the right to offset any such gain or income against any amounts
otherwise owed to the Participant by the Company or any Subsidiary (whether as wages, vacation pay or pursuant to any benefit plan or other compensatory arrangement). 

(b)    Accounting Restatement. If pursuant to any Award a Participant receives compensation calculated by reference
to financial statements that are subsequently required to be restated in a way that would decrease the value of such compensation, then the Participant will, upon the written request of the Committee and in the Committee’s sole discretion,
forfeit and repay to the Company the difference between what the Participant received during the period of three years preceding the date on which the Company becomes required to prepare the restatement and what the Participant should have received
based on the accounting restatement, in accordance with (i) the Company’s compensation recovery, “clawback” or similar policy, if any, as may be in effect from time to time and (ii) any compensation recovery,
“clawback” or similar policy made applicable by law, including the provisions of Section 945 of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the rules, regulations and requirements adopted thereunder by the
Securities and Exchange Commission and/or any national securities exchange on which the Company’s equity securities may be listed, as may be in effect from time to time (clauses (i) and (ii) collectively, the “Policy”). By
accepting an Award hereunder, each Participant acknowledges and agrees that the Policy shall apply to such Award, and all incentive-based compensation payable pursuant to such Award shall be subject to forfeiture and repayment pursuant to the terms
of the Policy. Although not required to give effect to the provisions of this Section 13.3(b), the Committee may, as it deems appropriate, amend the Plan to reflect the terms of the Policy, which shall not be deemed a material amendment. 

14.    Transfer, Leave of Absence, Etc. For purposes of the Plan, except as otherwise determined by the Committee,
the following events shall not be deemed a termination of Service: 
 (a)    a Participant’s transfer of employment
or termination with immediate rehire from the Company to a Subsidiary or from a Subsidiary to the Company, or from one Subsidiary to another Subsidiary, or a Participant’s change in status from employee to consultant, Non-Employee Director, or other personal service provider; or 
 (b)    an approved
leave of absence for military service or sickness, or for any other purpose approved by the Company, if the employee’s right to re-employment is guaranteed either by a statute or by contract or under the policy pursuant to which the leave of
absence was granted or if the Committee otherwise so provides in writing. 
 15.    General Provisions. 

15.1    Status of Plan. The Committee may (but shall not be obligated to) authorize the creation of trusts or other
arrangements to meet the Company’s obligations to deliver stock or make payments with respect to Awards. 

15.2    Award Agreement. Each Award under the Plan shall be evidenced by an Award Agreement, which may include
special terms for non-U.S. Participants in a separate appendix, in a written or electronic form approved 

  
 16 

 
by the Committee setting forth the number of shares of Common Stock subject to or otherwise underlying the Award, the exercise price, base price or purchase price of the Award, the time or times
at which an Award will become vested, exercisable or payable and the term of the Award. The Award Agreement may also set forth the effect on an Award of a Change in Control or a termination of Service under certain circumstances. The Award Agreement
shall be subject to and shall (or shall be deemed to) incorporate, by reference or otherwise, all of the applicable terms and conditions of the Plan, and may also set forth other terms and conditions applicable to the Award as determined by the
Committee consistent with the limitations of the Plan. The grant of an Award under the Plan shall not confer any rights upon the Participant holding such Award other than such terms, and subject to such conditions, as are specified in the Plan as
being applicable to such type of Award (or to all Awards) or as are expressly set forth in the Award Agreement. The Committee need not require the execution of an Award Agreement by a Participant, in which case, acceptance of the Award by the
Participant shall constitute agreement by the Participant to the terms, conditions, restrictions and limitations set forth in the Plan and the Award Agreement as well as the administrative guidelines of the Company in effect from time to time. In
the event of any conflict between the provisions of the Plan and any Award Agreement, the provisions of the Plan shall prevail. 

15.3    No Assignment or Transfer; Beneficiaries. Except as provided in Section 6.7(e) hereof or as otherwise
determined by the Committee, Awards under the Plan shall not be assignable or transferable by the Participant, and shall not be subject in any manner to assignment, alienation, pledge, encumbrance or charge. Notwithstanding the foregoing, in the
event of the death of a Participant, except as otherwise provided by the Committee in an Award Agreement, an outstanding Award may be exercised by or shall become payable to the Participant’s beneficiary as designated by the Participant in the
manner prescribed by the Committee or, in the absence of an authorized beneficiary designation, by a legatee or legatees of such Award under the participant’s last will or by such Participant’s executors, personal representatives or
distributees of such Award in accordance with the Participant’s will or the laws of descent and distribution. The Committee may provide in the terms of an Award Agreement or in any other manner prescribed by the Committee that the Participant
shall have the right to designate a beneficiary or beneficiaries who shall be entitled to any rights, payments or other benefits specified under an Award following the Participant’s death. 

15.4    Deferrals of Payment. The Committee may in its discretion permit a Participant to defer the receipt of
payment of cash or delivery of shares of Common Stock that would otherwise be due to the Participant by virtue of (a) the exercise of a right or the satisfaction of vesting or other conditions with respect to an Award or (b) an election to
receive shares of Common Stock (in lieu of compensation otherwise payable in cash) on a deferred basis pursuant to Section 11.3 hereof; provided, however, that such discretion shall not apply in the case of a Stock Option or Stock
Appreciation Right. If any such deferral is to be permitted by the Committee, the Committee shall establish rules and procedures relating to such deferral in a manner intended to comply with the requirements of Section 409A of the Code,
including, without limitation, the time when an election to defer may be made, the time period of the deferral and the events that would result in payment of the deferred amount, the interest or other earnings attributable to the deferral and the
method of funding, if any, attributable to the deferred amount. 
 15.5    No Right to Employment or Continued
Service. Nothing in the Plan, in the grant of any Award or in any Award Agreement shall confer upon any Eligible Person or any Participant any right to continue in the Service of the Company or any of its Subsidiaries or interfere in any way
with the right of the Company or any of its Subsidiaries to terminate the Service relationship of an Eligible Person or a Participant for any reason at any time. 

15.6    Rights as Stockholder. Except as may otherwise be provided herein, a Participant shall have no rights as a
holder of shares of Common Stock with respect to any unissued securities covered by an Award until the date the Participant become the holder of record of such securities. For Restricted Stock or Stock Awards subject to vesting, dividends shall be
accumulated and subject to any restrictions and risk of forfeiture to which the underlying Restricted Stock and Stock Award is subject. Subject to Section 4.5 hereof or as otherwise determined by the Committee, no adjustment or other provision
shall be made for dividends or other stockholder rights, except to the extent that the Award Agreement provides for dividend payments, dividend equivalent rights or other similar rights, 

  
 17 

 
it being understood that the Committee may provide for the payment of dividends and other distributions to the Participant at such times as paid to the stockholders or at the times of vesting or
otherwise set forth in the applicable Award Agreement. The Committee may determine in its discretion the manner of delivery of Common Stock to be issued under the Plan, which may be by delivery of stock certificates, electronic account entry into
new or existing accounts or any other means as the Committee, in its discretion, deems appropriate. The Committee may (a) require that the stock certificates (if any) be held in escrow by the Company (or any of its officers) for any shares of
Common Stock, (b) cause the shares of Common Stock to be legended in order to comply with the securities laws or other applicable restrictions or (c) should the shares of Common Stock be represented by book or electronic account entry
rather than a certificate, take such steps to restrict transfer of such shares of Common Stock as the Committee considers necessary or advisable. 

15.7    Trading Policy Restrictions. Option exercises and other Awards granted under the Plan shall be subject to
the Company’s insider trading policy or other trading or ownership policy-related restrictions, terms and conditions as in effect from time to time. 

15.8    Section 409A Compliance and Section 280G. 

(a)    Section 409A. To the maximum extent possible, it is intended that the Plan and all Awards hereunder are, and
shall be, exempt from or otherwise comply with the requirements of Section 409A of the Code, the regulations thereunder promulgated by the United States Department of Treasury (the “Treasury Regulations”) and other guidance
issued thereunder, and that the Plan and all Award Agreements shall be interpreted and applied by the Committee in a manner consistent with this intent in order to avoid the imposition of any additional Tax-Related Items under Section 409A of
the Code. In the event that any (i) provision of the Plan or an Award Agreement, (ii) Award, payment or transaction or (iii) other action or arrangement contemplated by the provisions of the Plan is determined by the Committee to not
comply with the applicable requirements of Section 409A of the Code, the Treasury Regulations and other guidance issued thereunder, the Committee shall have the authority to take such actions and to make such changes to the Plan or an Award
Agreement as the Committee deems necessary to comply with such requirements. No payment that constitutes deferred compensation under Section 409A of the Code that would otherwise be made under the Plan or an Award Agreement upon a termination
of Service will be made or provided unless and until such termination is also a “separation from service,” as determined in accordance with Section 409A of the Code. Notwithstanding the foregoing or anything elsewhere in the Plan or
an Award Agreement to the contrary, if a Participant is a “specified employee” as defined in Section 409A of the Code at the time of termination of Service with respect to an Award, then solely to the extent necessary to avoid the
imposition of any additional Tax- Related Items under Section 409A of the Code, the commencement of any payments or benefits under the Award shall be deferred until the date that is one day after six months following the Participant’s
termination of Service (or, if earlier, the date of death of the specified employee) and shall instead be paid (in a manner set forth in the Award Agreement) on the payment date that immediately follows the end of such six-month period (or death) or
as soon as administratively practicable within thirty (30) days thereafter, but in no event later than the end of the applicable taxable year. In no event whatsoever shall the Company be liable for any additional
Tax-Related Items, interest or penalties that may be imposed on a Participant by Section 409A of the Code or any damages for failing to comply with Section 409A of the Code. 

(b)    Section 280G. 

(i)    Anything in this Plan to the contrary notwithstanding, in the event that the receipt of all payments or
distributions by the Company in the nature of compensation to or for a Participant’s benefit, whether paid or payable pursuant to this Plan or otherwise (a “Payment”), would subject the Participant to the excise tax under
Section 4999 of the Code, the accounting firm which audited the Company immediately prior to the corporate transaction which results in the application of such excise tax (the “Accounting Firm”) shall determine whether to
reduce any of the Payments to the Reduced Amount (as defined below). The Payments shall be reduced to the Reduced Amount only if the Accounting Firm determines that the Participant would have a greater Net After-Tax

  
 18 

 
Receipt (as defined below) of aggregate Payments if the Participant’s Payments were reduced to the Reduced Amount. If such a determination is not made by the Accounting Firm, the Participant
shall receive all Payments to which the Participant is entitled. 
 (ii)    If the Accounting Firm determines that
aggregate Payments should be reduced to the Reduced Amount, the Company shall promptly give the Participant notice to that effect and a copy of the detailed calculation thereof. All determinations made by the Accounting Firm under this
Section 15.8(b) shall be made as soon as reasonably practicable and in no event later than sixty (60) days following the date of termination or such earlier date as requested by the Company. For purposes of reducing the Payments to the
Reduced Amount, such reduction shall be implemented by determining the Parachute Payment Ratio (as defined below) for each Payment and then reducing the Payments in order beginning with the Payment with the highest Parachute Payment Ratio. For
Payments with the same Parachute Payment Ratio, such Payments shall be reduced based on the time of payment of such Payments, with amounts having later payment dates being reduced first. For Payments with the same Parachute Payment Ratio and the
same time of payment, such Payments shall be reduced on a pro rata basis (but not below zero) prior to reducing Payments with a lower Parachute Payment Ratio. In all cases, the reduction of Payments shall be implemented in a manner that complies
with Section 409A of the Code. All other provisions of any agreement embodying the Payments shall remain in full force and effect. All fees and expenses of the Accounting Firm shall be borne solely by the Company. 

(iii)    As a result of the uncertainty in the application of Section 4999 of the Code at the time of the initial
determination by the Accounting Firm hereunder, it is possible that amounts will have been paid or distributed by the Company to or for the benefit of the Participant pursuant to this Agreement or otherwise which should not have been so paid or
distributed (the “Overpayment”) or that additional amounts which will have not been paid or distributed by the Company to or for the benefit of the Participant pursuant to this Agreement or otherwise could have been so paid or
distributed (the “Underpayment”), in each case, consistent with the calculation of the Reduced Amount hereunder. In the event that the Accounting Firm, based upon the assertion of a deficiency by the Internal Revenue Service against
either the Company or the Participant which the Accounting Firm believes has a high probability of success, determines that an Overpayment has been made, the Participant shall pay any such Overpayment to the Company together with interest at the
applicable federal rate provided for in Section 7872(f)(2) of the Code; provided, however, that no amount shall be payable by the Participant to the Company if and to the extent such payment would not either reduce the amount on
which the Participant is subject to tax under Section 1 and Section 4999 of the Code or generate a refund of such taxes. In the event that the Accounting Firm, based upon controlling precedent or substantial authority, determines that an
Underpayment has occurred, any such Underpayment shall be paid promptly (and in no event later than sixty (60) days following the date on which the Underpayment is determined) by the Company to or for the benefit of the Participant together
with interest at the applicable federal rate provided for in Section 7872(f)(2) of the Code. 
 (iv)    For
purposes hereof, the following terms have the meanings set forth below: (A) “Reduced Amount” shall mean the greatest amount of Payments that can be paid that would not result in the imposition of the excise tax under
Section 4999 of the Code if the Accounting Firm determines to reduce Payments pursuant to this Section 15.8(b), (B) “Net After-Tax Receipt” shall mean the present value (as determined in accordance with Sections
280G(b)(2)(A)(ii) and 280G(d)(4) of the Code) of a Payment net of all taxes imposed on the Participant with respect thereto under Sections 1 and 4999 of the Code and under applicable state and local laws, determined by applying the highest marginal
rate under Section 1 of the Code and under state and local laws which applied to the Participant’s taxable income for the immediately preceding taxable year, or such other rate(s) as the Participant certifies, in the Participant’s
sole discretion, as likely to apply to the Participant in the relevant tax year(s), and (C) ”Parachute Payment Ratio” shall mean a fraction the numerator of which is the present value (as determined in accordance with Sections
280G(b)(2)(A)(ii) and 280G(d)(4) of the Code) of the applicable Payment for purposes of Section 280G and the denominator of which is the intrinsic value of such Payment. 

  
 19 

 15.9    Securities and Exchange Control Law Compliance. No shares of
Common Stock will be issued or transferred pursuant to an Award unless and until all then applicable requirements imposed by U.S. federal, state, and foreign securities, exchange control and other laws, rules and regulations and by any regulatory
agencies having jurisdiction, and by any exchanges upon which the shares of Common Stock may be listed, have been fully met. As a condition precedent to the issuance of shares of Common Stock pursuant to the grant or exercise of an Award, the
Company may require the Participant to take any reasonable action to meet such requirements. The Committee may impose such conditions on any shares of Common Stock issuable under the Plan as it may deem advisable, including, without limitation,
restrictions under the Securities Act of 1933, as amended, under the requirements of any exchange upon which such shares of the same class are then listed, and under any other securities or other laws applicable to such shares. 

15.10    Substitute Awards in Corporate Transactions. Nothing contained in the Plan shall be construed to limit the
right of the Committee to grant Awards under the Plan in connection with the acquisition, whether by purchase, merger, consolidation or other corporate transaction, of the business or assets of any corporation or other entity. Without limiting the
foregoing, the Committee may grant Awards under the Plan to an employee, director or other personal service provider of another corporation who becomes an Eligible Person by reason of any such corporate transaction in substitution for awards
previously granted by such corporation or entity to such person. The terms and conditions of the substitute Awards may vary from the terms and conditions that would otherwise be required by the Plan solely to the extent the Committee deems necessary
for such purpose. Any such substitute awards shall not (a) reduce the number of shares of Common Stock available for issuance under the Plan, (b) be subject to or counted against the Award limits specified in Sections 4.3 or 4.4 hereof or
(c) replenish the Share Reserve upon the occurrence of any event set forth in Section 4.2 hereof, to the extent permitted under the rules of the Principal Exchange. 

15.11    Tax Withholding. The Participant shall be responsible for payment of any
Tax-Related Items or similar charges required by law to be paid or withheld from an Award or an amount paid in satisfaction of an Award, or otherwise applicable to the Participant. Any required Tax-Related Items withholdings shall be paid by the Participant on or prior to the payment or other event that results in taxable income in respect of an Award. Without limiting the foregoing, the Company shall have
the power and the right to deduct or withhold automatically from any amount deliverable under the Award or otherwise, or require a Participant to remit to the Company or the applicable Subsidiary, an amount necessary to satisfy Tax-Related Items
withholding requirements with respect to any taxable event arising as a result of the Plan. The Award Agreement may specify the manner in which the withholding obligation shall be satisfied with respect to the particular type of Award, which may
include, without limitation, permitting the Participant to elect to satisfy the withholding obligation by tendering shares of Common Stock to the Company or having the Company withhold a number of shares of Common Stock having a value at least
sufficient to satisfy the statutory amount of Tax-Related Items or similar charges required to be paid or withheld. 

15.12    Prohibition on Repricing. Except in the case of an adjustment as provided in Section 4.5 hereof and
subject to Section 15.10 hereof, the terms of outstanding Stock Options or Stock Appreciation Rights may not be amended, and action may not otherwise be taken without stockholder approval, to: (i) reduce the exercise price or base price of
outstanding Stock Options or Stock Appreciation Rights; (ii) cancel outstanding Stock Options or Stock Appreciation Rights in exchange for Options or Stock Appreciation Rights with an exercise price or base price that is less than the exercise
price or base price of the original Stock Options or Stock Appreciation Rights; or (iii) replace outstanding Stock Options or Stock Appreciation Rights in exchange for other Awards or cash at a time when the Stock Options or Stock Appreciation
Rights have a per share exercise price that is higher than the Fair Market Value of a share of Common Stock. 

15.13    Unfunded Plan. The adoption of the Plan and any reservation of shares of Common Stock or cash amounts by
the Company to discharge its obligations hereunder shall not be deemed to create a trust or other funded arrangement. Except upon the issuance of Common Stock pursuant to an Award, any rights of a Participant under the Plan shall be those of a
general unsecured creditor of the Company, and neither a Participant nor the Participant’s 

  
 20 

 
permitted transferees or estate shall have any other interest in any assets of the Company by virtue of the Plan. Notwithstanding any of the foregoing, the Company shall have the right to
implement or set aside funds in a grantor trust, subject to the claims of the Company’s creditors or otherwise, to discharge its obligations under the Plan. The Plan is not subject to the U.S. Employee Retirement Income Security Act of 1974, as
amended from time to time. 
 15.14    Other Compensation and Benefit Plans. The adoption of the Plan shall not
affect any other share incentive or other compensation plans in effect for the Company or any Subsidiary, nor shall the Plan preclude the Company or any Subsidiary from establishing any other forms of share incentive or other compensation or benefit
program for employees of the Company or any Subsidiary. The amount of any income deemed to be received by a Participant pursuant to an Award shall not constitute includable compensation for purposes of determining the amount of benefits to which a
Participant is entitled under any other compensation or benefit plan or program of the Company or a Subsidiary, including, without limitation, under any pension or severance benefits plan, except to the extent specifically provided by the terms of
any such plan. 
 15.15    Plan Binding on Transferees. The Plan shall be binding upon the Company, its
transferees and assigns, and the Participant, the Participant’s executor, personal representative(s), distributes, administrator, permitted transferees, permitted assignees, beneficiaries and legatee(s), as applicable. 

15.16    Severability. If any provision of the Plan or any Award Agreement shall be determined to be illegal or
unenforceable by any court of law in any jurisdiction, the remaining provisions hereof and thereof shall be severable and enforceable in accordance with their terms, and all provisions shall remain enforceable in any other jurisdiction. 

15.17    Governing Law; Jurisdiction; Waiver of Jury Trial. The Plan and each Award Agreement and all claims,
causes of action or proceedings (whether in contract, in tort, at law or otherwise) that may be based upon, arise out of or relate to the Plan or any Award Agreement shall be governed by the internal laws of the State of Delaware, excluding any
conflicts- or choice-of-law rule or principle that might otherwise refer construction or interpretation of the Plan to the substantive law of another jurisdiction. Each Participant and each party to an Award Agreement agrees that it shall bring all
claims, causes of action and proceedings (whether in contract, in tort, at law or otherwise) that may be based upon, arise out of or be related to the Plan or any Award Agreement exclusively in the Delaware Court of Chancery or, in the event (but
only in the event) that such court does not have subject matter jurisdiction over such claim, cause of action or proceeding, exclusively in the United States District Court for the District of Delaware (the “Chosen Court”), and
hereby (i) irrevocably submits to the exclusive jurisdiction of the Chosen Court, (ii) waives any objection to laying venue in any such proceeding in the Chosen Court, (iii) waives any objection that the Chosen Court is an
inconvenient forum or does not have jurisdiction over any party and (iv) agrees that service of process upon such party in any such claim or cause of action shall be effective if notice is given in accordance with such Award Agreement. 

15.18    No Fractional Shares. No fractional shares of Common Stock shall be issued or delivered pursuant to the
Plan or any Award, and the Committee shall determine (i) whether cash, other securities or other property shall be paid or transferred in lieu of any fractional shares of Common Stock or (ii) whether such fractional shares or any rights
thereto shall be canceled, terminated or otherwise eliminated (in the case of this clause (ii), with no consideration paid therefor). 

15.19    No Guarantees Regarding Tax Treatment. Neither the Company nor the Committee make any guarantees to any
person regarding the tax treatment of Awards or payments made under the Plan. Neither the Company nor the Committee has any obligation to take any action to prevent the assessment of any Tax-Related Items on any person with respect to any Award
under Section 409A of the Code, Section 4999 of the Code, Section 280G of the Code or otherwise and neither the Company nor the Committee shall have any liability to a person with respect thereto. 

  
 21 

 15.20    Awards to Non-U.S. Employees, Non-Employee Directors or
Consultants. With respect to grants of Awards to Eligible Persons residing in countries other than the United States in which the Company or any of its Subsidiaries operates or has employees, Non-Employee Directors, consultants or other personal
service providers, the Committee, in its sole discretion, shall have the power and authority to: 
 (a)    Determine and
modify the terms and conditions of any Award granted to Participants outside the United States to comply with applicable foreign laws, including, but not limited to (i) limiting the methods of payment of the exercise price or purchase price and
Tax-Related Items withholding, (ii) restricting the sale of shares of Common Stock subject to an Award, (iii) determining whether Awards shall be settled in cash, Common Stock or a combination
thereof, (iv) permitting or restricting the use of beneficiary designations, (v) limiting or requiring a deferral of the payment of cash or shares of Common Stock otherwise due in satisfaction of an Award, (vi) qualifying or
disqualifying an Award under a “tax advantaged” program, and (vii) requiring payment of employer social contributions due with respect to an Award as a condition of an Award; 

(b)    Take any action, before or after an Award is made, that it deems advisable to obtain approval or comply with any
necessary local government regulatory exemptions or approvals; and 
 (c)    Establish subplans and Award Agreements and
modify exercise procedures and other terms and procedures, to the extent such actions may be necessary or advisable. Any subplans to the Plan established under this Section 15.20 by the Committee shall be attached to this Plan document as
appendices. 
 16.    Term; Amendment and Termination; Stockholder Approval. 

16.1    Term. The Plan, which was duly adopted and approved by the Board of Directors of the Company by resolution
at a meeting held on the March 15, 2018 shall become effective as of the date the shareholders approve the Plan (the “Effective Date”). The Plan shall continue in effect until terminated by the Committee in
accordance with Section 16.2 hereof. 
 16.2    Amendment and Termination. The Committee may from time to
time and in any respect, amend, modify, suspend or terminate the Plan; provided, that, except as provided in Section 15.8, Section 15.20 or as otherwise determined by the Committee as it deems necessary to comply with applicable
laws, no amendment, modification, suspension or termination of the Plan shall adversely affect any Award theretofore granted without the consent of the Participant or the permitted transferee of the Award. The Committee may seek the approval of any
amendment, modification, suspension or termination by the Company’s stockholders to the extent it deems necessary or advisable in its discretion for purposes of compliance with Section 422 of the Code, the listing requirements of the
Principal Market or other exchange or securities market or for any other purpose. 

*            *           
 * 

  
 22

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}]]